
Shalby (SHALBY) | Stock Overview & Key Data
Shalby Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹339.50 on January 22, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Shalby SHALBY | 28.58B Small-cap | 7.74% | 35.22% | 42.91% | 25.35% | 15.19% | -1.79% | 99.07% | 178.07% |
Apollo Hospitals APOLLOHOSP | 1.08T Large-cap | -0.81% | -3.70% | -1.53% | 11.66% | 1.08% | 9.98% | 69.53% | 227.15% |
Max Healthcare MAXHEALTH | 1.05T Large-cap | -4.82% | -7.99% | -17.84% | -4.65% | -6.18% | 15.42% | 157.02% | 865.85% |
Indraprastha Medical INDRAMEDCO | 42.43B Small-cap | 3.48% | -3.24% | -7.50% | 14.75% | -14.65% | 9.20% | 642.22% | 819.28% |
Dr. Agarwal's Eye DRAGARWQ | 23.46B Small-cap | 2.98% | 9.84% | 14.47% | 16.54% | -23.53% | 4.92% | 358.10% | 1,895.43% |
GPT Healthcare GPTHEALTH | 12.22B Small-cap | 0.07% | -2.76% | 0.09% | -12.37% | -19.15% | -16.71% | -22.75% | -22.75% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SHALBY's 52-week high and low?
- In the last 52 weeks, Shalby reached a high of ₹278.15 (on October 3, 2024) and a low of ₹177.25 (on June 16, 2025).
- What is the market cap and P/E ratio for SHALBY?
- Curious about Shalby's size and valuation? Its market capitalization stands at 28.58B. When it comes to valuation, the P/E ratio (trailing twelve months) is 1,122.67, and the forward P/E (looking ahead) is 28.05.
- Does SHALBY pay dividends? If so, what's the yield?
- Yes, Shalby is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.65%, and the company has paid an average of ₹1.08 per share annually over the past 3 years.
- Who are Shalby's main competitors or similar companies to consider before investing?
When looking at Shalby, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Apollo Hospitals
APOLLOHOSP1.08T Healthcare Medical Care Facilities 9.98% 69.53% Max Healthcare
MAXHEALTH1.05T Healthcare Medical Care Facilities 15.42% 157.02% Indraprastha Medical
INDRAMEDCO42.43B Healthcare Medical Care Facilities 9.20% 642.22% Dr. Agarwal's Eye
DRAGARWQ23.46B Healthcare Medical Care Facilities 4.92% 358.10% GPT Healthcare
GPTHEALTH12.22B Healthcare Medical Care Facilities -16.71% -22.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Shalby Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Shalby's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.63%, the Debt to Equity ratio from the most recent quarter is 47.82, and its Gross Profit Margin stands at 39.66%.
- What is the recent revenue and earnings growth for SHALBY?
- Looking at Shalby's growth, its revenue over the trailing twelve months (TTM) was INR11B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.30%, and quarterly earnings saw a YoY growth of -46.30%.
- How much of SHALBY stock is held by insiders and institutions?
- Wondering who owns Shalby stock? Company insiders (like executives and directors) hold about 76.56% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.17%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.